Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,991
Closed -$204K 173
2023
Q1
$204K Sell
4,991
-113
-2% -$4.88K 0.04% 166
2022
Q4
$262K Sell
5,104
-267
-5% -$12.8K 0.06% 158
2022
Q3
$235K Buy
5,371
+288
+6% +$14K 0.06% 149
2022
Q2
$267K Buy
5,083
+32
+0.6% +$1.63K 0.07% 142
2022
Q1
$261K Buy
5,051
+1,335
+36% +$69.3K 0.06% 147
2021
Q4
$219K Buy
+3,716
New +$184K 0.05% 148
2019
Q2
Sell
-9,768
Closed -$370K 72
2019
Q1
$370K Buy
+9,768
New +$391K 0.22% 51

Other funds holding PFE

ERn Financial LLC's PFE Position: Q2 2023 in Review

ERn Financial LLC sold out of Pfizer (PFE) in Q2 2023, closing a stake of 4,991 shares — an estimated $204K sold.

ERn Financial LLC first reported a position in PFE in Q1 2019 and held it in 7 quarters. The position peaked at $370K in Q1 2019. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

  • ERn Financial LLC reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
  • ERn Financial LLC sold 4,991 Pfizer shares in Q2 2023, an estimated $204K.
  • ERn Financial LLC first reported a position in Pfizer in Q1 2019 and held it in 7 quarters.
  • ERn Financial LLC's Pfizer position peaked at $370K in Q1 2019.
  • 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on ERn Financial LLC's 13F filing for Q2 2023, filed 10 Aug 2023.